MSH2 and rectal cancer: Whereas, germline mutation frequency of hMLH1/hMSH2 gene was not significantly different in proximal colon cancer (17.3%, 14/81), distal colon cancer (17.8%, 13/73) and rectal cancer (10.1%, 28/276) (p = 0.09).